International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a …

International Stem Cell Corporation (OTCBB: ISCO ) ( www.intlstemcell.com ), the first company to perfect a method of creating human “parthenogenetic” stem cells, which are derived from unfertilized human eggs, is working with tissue engineers at Cytograft Tissue Engineering , (Novato, CA), to design a custom cell culture medium to cultivate living human vascular grafts; grafts which are …

[Read the full article here]

Related News:
Novato’s ‘Cytograft’ in on stem-cell breakthrough
Stem Cell Research and Tissue Engineering A Boon for Dental Tissue …
Tissue-engineered grafts composed of adult stem cells could 1 day replace synthetic vascular bypass grafts

2 Responses to “International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a …”

  1. Netha Ulahannan on March 19th, 2009 at 10:06 pm

    Hi,
    Iam a recent graduate in biomedical engineering. I am interested in pursuing stem cell research. Could you please let me know how I should proceed.

    Thank you
    Netha

  2. Hi Netha,

    I am not the right person to give you advice on your career. I am not in the medical field. I am only providing the latest news on stem cell development. You would be better off going to your school career development department.

    Good luck.

Leave a Reply